Response to antiangiogenic therapy in the posterior tumor part was accompanied with a distinct reduction in peritumoral edema (Fig. 2a) which was associated with an increase in VHL-area (black-framed VHLs in Fig. 2b). The gene discussed is VHL; the disease is neoplasm.